Dear Sir, Anemia is a severe problem in patients with chronic renal insufficiency. While multiple factors can cause anemia in chronic renal failure, decreased erythropoietin (Epo) production is the most important cause [1] . Another cause may be secondary hyperparathyroidism that has not been clearly explained. It was suggested that parathormone (PTH) may play a role by its direct inhibitory effect on erythropoiesis and/or induction of bone marrow fibrosis [2] . We studied the effect of Epo therapy on secondary hyperparathyroidism in hemodialysis (HD) patients. Twenty-four HD patients who were treated with Epo, 9 males and 15 females, mean age 45.6 ± 14.5 years (range: 18-75) were included in the study (group I). The control group consisted of 17 age-and sex-matched HD patients who were not prescribed Epo (group II). Patients are dialyzed for 4 h, 2-3 times a week. All patients received calcium carbonate (3-9 g/day), calcitriol (0.25 mg/day), and a low-protein diet consisting of 800 mg phosphorus. Group I patients were treated with Epo 60-70 IU/kg s.c. twice a week. In all patients, serum calcium (Ca), phosphorus (P) and alkaline phosphatase (ALP) values were measured monthly, and Nterminal PTH values were measured every 3 months. The serum values of Ca, P, ALP and PTH at baseline and at the third month were compared in the two groups by the Student's t test. All the measurements are shown in table 1. With Epo administration in group I, the mean hematocrit value rose from 18.6 ± 2.6 to 24.8 ± 3.5% (p < 0.001) while the serum value of Ca increased significantly (p < 230.5 ± 295.8 * p < 0.05; ** p < 0.03; *** p < 0.01; **** p < 0.001. is excessive PTH secretion in chronic renal failure and that this status may contribute to the anemia seen in uremic patients [3] . Improved anemia in patients with primary hyperparathyroidism has been reported after surgical ablation of parathyroid adenoma [4] . Also, it has been noted that parathyroid-ectomy may improve the anemia in patients with chronic renal failure. Unfortunately, observations on PTH-related anemia 0.001). The serum values of ALP and PTH decreased significantly (p < 0.001 ‚ p < 0.05). The mean serum value of P also decreased, but the difference was not significant (p > 0.05). In group II, the mean serum values of P, ALP and PTH decreased but the difference was not significant with the exception of the serum P values (p < 0.03). A number of studies have shown that one of the major causes of renal osteodystrophy KARGER E-Mail karger@karger.ch Fax+ 41 61 306 12 34
